Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
RG-6035 by Genentech USA for Primary Progressive Multiple Sclerosis (PPMS): Likelihood of Approval
RG-6035 is under clinical development by Genentech USA and currently in Phase I for Primary Progressive Multiple Sclerosis (PPMS). According...